Vaxcyte, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Vaxcyte, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Vaxcyte, Inc. Assets for the quarter ending September 30, 2024 was $3.56B, a 138% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$3.56B	+$2.06B	+138%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$2.09B	+$584M	+38.9%	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$2.09B	+$1.08B	+107%	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$1.41B	+$402M	+39.9%	Dec 31, 2023	10-Q	2024-11-05
Q3 2023	$1.5B	+$1.08B	+263%	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	$1.5B	+$1.09B	+265%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$1.01B	+$605M	+150%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$1.01B	+$682M	+210%	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$412M	+$58M	+16.4%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$412M	+$53.6M	+15%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$403M	+$20.4M	+5.33%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$324M	-$68.5M	-17.4%	Dec 31, 2021	10-K	2023-02-27
Q3 2021	$354M	-$49.7M	-12.3%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$358M	-$58.2M	-14%	Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$382M			Mar 31, 2021	10-Q	2021-05-11
Q4 2020	$393M	+$327M	+498%	Dec 31, 2020	10-K	2022-02-28
Q3 2020	$404M			Sep 30, 2020	10-Q	2020-11-12
Q2 2020	$416M			Jun 30, 2020	10-Q	2020-08-12
Q4 2019	$65.7M			Dec 31, 2019	10-K	2021-03-29

* An asterisk sign (*) next to the value indicates that the value is likely invalid.